Table 2.
Participant Demographic, Behavioral, and HIV Clinical Characteristics by Mpox Vaccination Status, N = 373.
| Mpox Vaccination Status | |||||
|---|---|---|---|---|---|
| Characteristic | Yes N = 101 |
No, But Plan to Vaccinate N = 129 |
No Plans to Vaccinate N = 143 |
Total N = 373 |
p-Value |
| Demographics | |||||
| Age (median, IQR) | 46.0 [38.0;56.0] | 57.0 [47.0;63.0] | 56.0 [44.0;63.0] | 54.0 [43.0;62.0] | <0.0001 |
| Gender * | <0.0001 | ||||
| Male | 97 (96.0%) | 96 (74.4%) | 82 (57.7%) | 275 (73.9%) | |
| Female | 2 (2.0%) | 28 (21.7%) | 59 (41.5%) | 89 (23.9%) | |
| Other | 2 (2.0%) | 5 (3.9%) | 1 (0.7%) | 8 (2.2%) | |
| Race * | 0.0015 | ||||
| Black/African American | 67 (67.0%) | 105 (83.3%) | 117 (84.8%) | 289 (79.4%) | |
| All other | 33 (33.0%) | 21 (16.7%) | 21 (15.2%) | 75 (20.6%) | |
| Hispanic | 0.1314 | ||||
| Yes | 7 (6.9%) | 5 (3.9%) | 1 (0.7%) | 13 (3.5%) | |
| No | 90 (89.1%) | 120 (93.0%) | 137 (95.8%) | 347 (93.0%) | |
| Decline to answer | 4 (4.0%) | 4 (3.1%) | 5 (3.5%) | 13 (3.5%) | |
| Education * | <0.0001 | ||||
| Less than a high school diploma | 2 (2.0%) | 10 (7.8%) | 15 (10.6%) | 27 (7.3%) | |
| Grade 12 or GED (High school graduate) | 16 (15.8%) | 48 (37.5%) | 44 (31.0%) | 108 (29.1%) | |
| College 1 year to 3 years (Some college or technical school) | 21 (20.8%) | 37 (28.9%) | 40 (28.2%) | 98 (26.4%) | |
| College 4 years or more (College graduate) | 62 (61.4%) | 33 (25.8%) | 43 (30.3%) | 138 (37.2%) | |
| Mode of HIV transmission ** | <0.0001 | ||||
| MSM | 73 (73.0%) | 54 (43.2%) | 39 (27.5%) | 166 (45.2%) | |
| Heterosexual | 7 (7.0%) | 38 (30.4%) | 55 (38.7%) | 100 (27.2%) | |
| IDU | 0 (0%) | 6 (4.8%) | 14 (9.9%) | 20 (5.4%) | |
| Perinatal | 0 (0%) | 2 (1.6%) | 9 (6.3%) | 11 (3.0%) | |
| Other | 20 (20.0%) | 25 (20.0%) | 25 (17.6%) | 70 (19.1%) | |
| Relationship Status * | 0.1591 | ||||
| Divorced, separated, or widowed | 15 (15.5%) | 24 (18.9%) | 38 (27.3%) | 77 (21.2%) | |
| Married or living with partner | 18 (18.6%) | 28 (22.0%) | 31 (22.3%) | 77 (21.2%) | |
| Single, never married | 61 (62.9%) | 74 (58.3%) | 66 (47.5%) | 201 (55.4%) | |
| Other | 3 (3.1%) | 1 (0.8%) | 4 (2.9%) | 8 (2.2%) | |
| Number of people living in the household * | 0.0404 | ||||
| 1 | 53 (52.5%) | 55 (43.0%) | 56 (39.2%) | 164 (44.1%) | |
| 2 | 36 (35.6%) | 39 (30.5%) | 45 (31.5%) | 120 (32.3%) | |
| 3 | 5 (5.0%) | 16 (12.5%) | 19 (13.3%) | 40 (10.8%) | |
| 4 | 6 (5.9%) | 5 (3.9%) | 8 (5.6%) | 19 (5.1%) | |
| 5+ | 1 (1.0%) | 13 (10.2%) | 15 (10.5%) | 29 (7.8%) | |
| Annual household income | 0.0006 | ||||
| <$25,000 | 12 (11.9%) | 45 (34.9%) | 50 (35.0%) | 107 (28.7%) | |
| $25,000–$34,999 | 12 (11.9%) | 15 (11.6%) | 20 (14.0%) | 47 (12.6%) | |
| $35,000–$49,999 | 10 (9.9%) | 17 (13.2%) | 10 (7.0%) | 37 (9.9%) | |
| $50,000–$99,999 | 22 (21.8%) | 21 (16.3%) | 26 (18.2%) | 69 (18.5%) | |
| $10,000+ | 31 (30.7%) | 13 (10.1%) | 21 (14.7%) | 65 (17.4%) | |
| Don’t know/Not sure | 5 (5.0%) | 10 (7.8%) | 7 (4.9%) | 22 (5.9%) | |
| Decline to answer | 9 (8.9%) | 8 (6.2%) | 9 (6.3%) | 26 (7.0%) | |
| Survey Completion Period | 0.0052 | ||||
| August-December 22 | 39 (38.6%) | 77 (59.7%) | 67 (46.9%) | 183 (49.1%) | |
| January-April 23 | 62 (61.4%) | 52 (40.3%) | 76 (53.1%) | 190 (50.9%) | |
| Self-Reported Behavioral Parameters | |||||
| Worry about Mpox * | <0.0001 | ||||
| A lot | 18 (18.0%) | 31 (24.2%) | 9 (6.3%) | 58 (15.7%) | |
| A little | 49 (49.0%) | 70 (54.7%) | 47 (33.1%) | 166 (44.9%) | |
| Not at all | 33 (33.0%) | 27 (21.1%) | 86 (60.6%) | 146 (39.5%) | |
| Received COVID-19 vaccine * | 0.0383 | ||||
| Yes | 96 (95.0%) | 123 (95.3%) | 125 (88.0%) | 344 (92.5%) | |
| No | 5 (5.0%) | 6 (4.7%) | 17 (12.0%) | 28 (7.5%) | |
| Received a flu vaccine * | 0.3228 | ||||
| Yes | 83 (83.8%) | 98 (76.6%) | 108 (76.6%) | 289 (78.5%) | |
| No | 16 (16.2%) | 30 (23.4%) | 33 (23.4%) | 79 (21.5%) | |
| HIV and Clinical Parameters | |||||
| Years since HIV diagnosis (median, IQR) * | 15.6 [10.3;22.4] | 19.8 [13.5;28.4] | 20.3 [13.4;27.8] | 18.7 [12.7;26.7] | 0.0019 |
| Chlamydia test in past 18 months * | 0.1334 | ||||
| Yes | 53 (64.6%) | 62 (58.5%) | 57 (50.4%) | 172 (57.1%) | |
| No | 29 (35.4%) | 44 (41.5%) | 56 (49.6%) | 129 (42.9%) | |
| Gonorrhea test in past 18 months * | 0.0981 | ||||
| Yes | 53 (63.9%) | 63 (56.8%) | 59 (48.8%) | 175 (55.6%) | |
| No | 30 (36.1%) | 48 (43.2%) | 62 (51.2%) | 140 (44.4%) | |
| Syphilis test in past 18 months * | 0.3144 | ||||
| Yes | 61 (73.5%) | 89 (80.2%) | 87 (71.9%) | 237 (75.2%) | |
| No | 22 (26.5%) | 22 (19.8%) | 34 (28.1%) | 78 (24.8%) | |
| Any STI in the past 18 months * | 0.0009 | ||||
| Yes | 15 (18.3%) | 7 (6.6%) | 4 (3.5%) | 26 (8.6%) | |
| No | 67 (81.7%) | 99 (93.4%) | 109 (96.5%) | 275 (91.4%) | |
| Currently on ART * | 0.6269 | ||||
| Yes | 80 (84.2%) | 95 (79.2%) | 106 (82.2%) | 281 (81.7%) | |
| No | 15 (15.8%) | 25 (20.8%) | 23 (17.8%) | 63 (18.3%) | |
| Latest CD4 count >500 cells/mm3 * | 0.0007 | ||||
| Yes | 82 (82.0%) | 90 (72.6%) | 82 (59.4%) | 254 (70.2%) | |
| No | 18 (18.0%) | 34 (27.4%) | 56 (40.6%) | 108 (29.8%) | |
| Last VL suppressed (VL < 200 copies/mL * | 0.1008 | ||||
| Yes | 80 (92.0%) | 112 (94.9%) | 117 (87.3%) | 309 (91.2%) | |
| No | 7 (8.0%) | 6 (5.1%) | 17 (12.7%) | 30 (8.8%) | |
| Charlson Score (QCCI) | |||||
| 0 | 63 (62.4%) | 46 (36.2%) | 60 (42.0%) | 169 (45.6%) | <0.001 |
| 1 | 15 (14.9%) | 37 (29.1%) | 32 (22.4%) | 84 (22.6%) | |
| 2+ | 23 (22.8%) | 44 (34.6%) | 51 (35.7%) | 118 (31.8%) | |
| Missing | 0 | 2 | 0 | 2 | |
* Excludes missing responses: gender identity (n = 1); race (n = 9); relationship status (n = 10); education (n = 2); number of people in household (n- = 1); mode of HIV transmission (n = 6); worry about mpox (n = 3); chlamydia testing (n = 72); gonorrhea testing (n = 58); syphilis testing (n = 58); any STI in past 18 months (n = 72); received COVID vaccine (n = 1); received flu vaccine (n = 5); current ART (n = 29); latest CD4 count and CD4 above 500 cells/mm3 (n = 11); latest VL suppressed (n = 34); years since HIV diagnosis (n = 7). ** Mode of transmission, HIV, and other clinical parameters are based on DC Cohort data and not self-reported. All other variables were self-reported in the survey.